Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2005
10/27/2005US20050239835 controlling weight gain; 1-(1-amino-2-phenylethylcarbonyl)-4-cyclohexylpiperidine compounds
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239818 acetic acid (3RS,4aRS,10bRS)-6-(3,4-bis-cyclopropylmethoxyphenyl)-8,9-dimethoxy-(1,2,3,4,4a,10b)-hexahydrophenanthridin-3-yl ester, phosphodiesterase inhibitor; antiinflammatory, bronchodilator agent; bronchitis, allergic bronchitis, asthma, COPD, psoriasis, eczema, osteoarthritis, rheumatoid arthritis
10/27/2005US20050239817 Acetic acid 6-(3,4-bis-cyclopropylmethoxy-phenyl)-8,9-dimethoxy-(1,2,3,4,4a,10b)-hexahydrophenanthridin-2-yl ester; low toxicity; high bioavailability; large therapeutic breadth; side effects reduction; industrial scale; antiinflammatory agent, asthma, COPD, allergic rhinitis or Crohn's disease
10/27/2005US20050239789 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea
10/27/2005US20050239786 Triazole derivatives as tachykinin receptor antagonists
10/27/2005US20050239776 Tachykinin receptor antagonists
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
10/27/2005US20050239201 Methods of inducing differentiation of stem cells into a specific cell lineage
10/27/2005US20050239170 Alpha-MSH related compounds and methods of use
10/27/2005US20050239169 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/27/2005US20050239163 Cloning, expression and functional characterization of a mammalian DNA-R gene; polypetide having amino acid sequence with deletion at 1133 1171 amino acids
10/27/2005US20050238670 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections
10/27/2005CA2562391A1 Solid pharmaceutical preparation
10/27/2005CA2562369A1 Condensed pyridine derivatives useful as a28 adenosine receptor antagonists
10/27/2005CA2558331A1 Use of a pyrazole derivative for producing medicaments that are useful in preventing and treating chronic bronchitis and chronic obstructive bronchopneumopathy
10/26/2005EP1589013A2 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
10/26/2005EP1589009A1 Vitamin d3 lactone derivative
10/26/2005EP1588706A2 Use of AT1 receptor antagonists or AT2 receptor modulator for the treatment of conditions or diseases associated with the increase of AT1 or AT2 receptors.
10/26/2005EP1587838A2 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
10/26/2005EP1587534A1 Use of tff2, or agents inducing tff2, in the therapy of allergies
10/26/2005EP1587482A2 Anti-inflammatory compositions and uses thereof
10/26/2005EP1397354B1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1242048B1 Inhalation particles
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005CN1688580A Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
10/26/2005CN1688578A Phosphodiesterase 4 inhibitors
10/26/2005CN1688577A Triazaspiro [5.5] undecane derivatives and drugs comprising the same as the active ingredient
10/26/2005CN1688572A Piperidinyl targeting compounds that selectively bind integrins
10/26/2005CN1688550A 2, 5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12
10/26/2005CN1688549A Compound having TGF-beta inhibitory activity and medicinal composition containing the same
10/26/2005CN1688548A Process for preparing quinolin antibiotic intermediates
10/26/2005CN1688532A Composition based on substituted 1, 3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
10/26/2005CN1688336A Mycoplasma gallisepticum formulation, its mycoplasma strain k5054 and its application
10/26/2005CN1688308A Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs
10/26/2005CN1224628C Preparation of solanine sulfurate and its use in medicine
10/26/2005CN1224624C 1, 8-naphthyridin-2 (1H)-one derivatives
10/26/2005CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
10/26/2005CN1224423C Pharmaceutical composition improved in peroral absorbability
10/26/2005CN1224419C Orally administered peptides to ameliorate a therosclerosis
10/26/2005CN1224382C Method for preparing medicine for relieving cough and reducing sputum
10/25/2005US6958387 Human serpin polypeptides
10/25/2005US6958357 Central nervous system disorders; antiallergens; respiratory system disorders
10/25/2005US6958350 Chemical compounds
10/25/2005US6958349 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/25/2005US6958344 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/25/2005US6958343 Treating psoriasis, a disease in which angiogenesis is associated with raised CXCR2 chemokine levels, or COPD.
10/25/2005US6958336 Anticancer agents; immunosuppressants; antiallergens; antiinflammatory agents
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005CA2359708C Ketolide antibiotics
10/25/2005CA2332461C New benzenesulfonamide derivatives, their method of preparation and the pharmaceutical compositions containing them
10/25/2005CA2329172C Storage stable extended release oral dosage composition comprising desloratadine and pseudoephedrine
10/20/2005WO2005097996A1 Novel mite allergen
10/20/2005WO2005097803A1 Novel water-soluble prodrug
10/20/2005WO2005097775A1 Piperidine derivates for the treatment of chemokines mediared disease
10/20/2005WO2005097151A1 Antioxidant composition and products containing the same
10/20/2005WO2002097033A3 Antibodies that immunospecifically bind to trail receptors
10/20/2005US20050234118 Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/20/2005US20050234117 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level
10/20/2005US20050234102 Inhibiting the proteolytic activity of cathepsin S, comprising exposing cathepsin S to compounds such as 1-[4-(5-Chloro-1H-indol-3-yl)-piperidin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol
10/20/2005US20050234090 Modulators of chemokine receptor activity
10/20/2005US20050234088 Urea substituted imidazoquinoline ethers
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234077 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234056 Imidazoquinoline derivatives as adenosine A3 receptor ligands
10/20/2005US20050234041 Substituted 1-benzazepines and derivatives thereof
10/20/2005US20050234036 3-(2-tetrahydrofuryl-methyl)-2-thioxanthine; neuroinflammatory disorders; pain, cancers, rheumatic arthritis, neurodegenerative diseases
10/20/2005US20050234035 New salts
10/20/2005US20050234029 Compounds
10/20/2005US20050234022 Use of 2-alkoxyphenyl-substituted imidazotriazinones
10/20/2005US20050234017 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050233969 Analogues of GLP-1
10/20/2005US20050233447 A cell simultaneously expressing albumin protein and a membrane-associated CD14 surface antigen; expresses a mRNA sequence typical of hepatocytes selected from the group consisting of alpha-fetoprotein, carbamyl phosphate synthetase I, coagulation factor II, and coagulation factor VII
10/20/2005US20050232998 Dry powder inhalant composition
10/20/2005US20050232942 Virulence genes, proteins, and their use
10/20/2005US20050232898 Stabilized protein compositions
10/20/2005CA2563887A1 Mite allergen zen 1
10/20/2005CA2563502A1 Novel water-soluble prodrug
10/20/2005CA2561164A1 Steroid sparing agents and their use
10/20/2005CA2560649A1 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase
10/20/2005CA2560311A1 Protein kinase c inhibitors for the treatment of autoimmune diseases and of transplant rejection
10/20/2005CA2560131A1 Compounds for treating proliferative processes
10/19/2005EP1586574A1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1586564A1 8-azaprostaglandin derivatives and medicinal uses thereof
10/19/2005EP1586550A1 Lipoxin compounds and their use
10/19/2005EP1586347A1 Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
10/19/2005EP1585512A1 Compositions and methods for improving the condition of patients suffering from copd and other diseases
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1487272B1 Choline-silicic acid complex with osmolytes and divalent trace elements
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1401837B1 Purine derivatives as a2b adenosine receptor antagonists
10/19/2005EP1397170B1 Safety shield system for prefilled syringes
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP0846173B1 Use of an anti-interleukin-9 antibody for the preparation of a medicament for the treatment of asthma
1 ... 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 ... 878